These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 37421509)

  • 41. Review of antifungal therapy and the severity index for assessing onychomycosis: part I.
    Baran R; Hay RJ; Garduno JI
    J Dermatolog Treat; 2008; 19(2):72-81. PubMed ID: 18484426
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of Different Nail Penetration Enhancers in Solid Lipid Nanoparticles Containing Terbinafine Hydrochloride for Treatment of Onychomycosis.
    Abobakr FE; Fayez SM; Elwazzan VS; Sakran W
    AAPS PharmSciTech; 2021 Jan; 22(1):33. PubMed ID: 33404930
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Onychomycosis: An Updated Review.
    Leung AKC; Lam JM; Leong KF; Hon KL; Barankin B; Leung AAM; Wong AHC
    Recent Pat Inflamm Allergy Drug Discov; 2020; 14(1):32-45. PubMed ID: 31738146
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High failure rate of transungal drug delivery: need for new strategies.
    Tiwary AK; Sapra B
    Ther Deliv; 2017 Mar; 8(5):239-242. PubMed ID: 28361611
    [No Abstract]   [Full Text] [Related]  

  • 45. Effect of a novel penetration enhancer on the ungual permeation of two antifungal agents.
    Traynor MJ; Turner RB; Evans CR; Khengar RH; Jones SA; Brown MB
    J Pharm Pharmacol; 2010 Jun; 62(6):730-7. PubMed ID: 20636860
    [TBL] [Abstract][Full Text] [Related]  

  • 46.
    Kubota-Ishida N; Takei-Masuda N; Kaneda K; Nagira Y; Chikada T; Nomoto M; Tabata Y; Takahata S; Maebashi K; Hui X; Maibach HI
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29084749
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bacterial nanocellulose patches as a carrier for hydrating formulations to improve the topical treatment of nail diseases.
    Bellmann T; Luber R; Kischio L; Karl B; Pötzinger Y; Beekmann U; Kralisch D; Wiegand C; Fischer D
    Int J Pharm; 2022 Nov; 628():122267. PubMed ID: 36209980
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Recent progress on the topical therapy of onychomycosis.
    Alley MR; Baker SJ; Beutner KR; Plattner J
    Expert Opin Investig Drugs; 2007 Feb; 16(2):157-67. PubMed ID: 17243936
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Penetrance of Topical Nail Therapy: Limitations and Current Enhancements.
    Phan K; Kaur K; Wright K; Tran S; Stewart B; Brown M; Vlahovic TC
    Clin Podiatr Med Surg; 2021 Oct; 38(4):535-540. PubMed ID: 34538431
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Investigation on utility of some novel terpenes on transungual delivery of fluconazole for the management of onychomycosis.
    Adin SN; Gupta I; Ali A; Aqil M; Mujeeb M; Sultana Y
    J Cosmet Dermatol; 2022 Oct; 21(10):5103-5110. PubMed ID: 35390220
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Improved Methods for Assessing Therapeutic Potential of Antifungal Agents against Dermatophytes and Their Application in the Development of NP213, a Novel Onychomycosis Therapy Candidate.
    Mercer DK; Stewart CS; Miller L; Robertson J; Duncan VMS; O'Neil DA
    Antimicrob Agents Chemother; 2019 May; 63(5):. PubMed ID: 30858219
    [TBL] [Abstract][Full Text] [Related]  

  • 52. TranScreen-N: Method for rapid screening of trans-ungual drug delivery enhancers.
    Murthy SN; Vaka SR; Sammeta SM; Nair AB
    J Pharm Sci; 2009 Nov; 98(11):4264-71. PubMed ID: 19363796
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Recent Patents on Permeation Enhancers for Drug Delivery Through Nails.
    Kreutz T; de Matos SP; Koester LS
    Recent Pat Drug Deliv Formul; 2019; 13(3):203-218. PubMed ID: 31663846
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ciclopirox delivery into the human nail plate using novel lipid diffusion enhancers.
    Hafeez F; Hui X; Selner M; Rosenthal B; Maibach H
    Drug Dev Ind Pharm; 2014 Jun; 40(6):838-44. PubMed ID: 23600655
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Iontophoretic drug delivery across the nail.
    Delgado-Charro MB
    Expert Opin Drug Deliv; 2012 Jan; 9(1):91-103. PubMed ID: 22149385
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Optimized Ciclopirox-Based Eudragit RLPO Nail Lacquer: Effect of Endopeptidase Enzyme as Permeation Enhancer on Transungual Drug Delivery and Efficiency Against Onychomycosis.
    Khattab A; Shalaby S
    AAPS PharmSciTech; 2018 Apr; 19(3):1048-1060. PubMed ID: 29138987
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Therapeutic treatment strategies for the management of onychomycosis: a patent perspective.
    Chakraborty S; Sanshita ; Singh I
    Expert Opin Ther Pat; 2023; 33(9):613-630. PubMed ID: 37800854
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Emerging topical onychomycosis therapies - quo vadis?
    Elkeeb R; Hui X; Murthy N; Maibach HI
    Expert Opin Emerg Drugs; 2014 Dec; 19(4):489-95. PubMed ID: 25401504
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ciclopirox nail lacquer topical solution 8% in the treatment of toenail onychomycosis.
    Gupta AK; Fleckman P; Baran R
    J Am Acad Dermatol; 2000 Oct; 43(4 Suppl):S70-80. PubMed ID: 11051136
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Recent advances in therapies for onychomycosis and its management.
    Gupta AK; Stec N
    F1000Res; 2019; 8():. PubMed ID: 31297182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.